Creative Biolabs is a global biotechnology company with years of experience in helping our customers develop their immune checkpoint inhibitors, such as monoclonal antibodies (mAbs), recombinant proteins, peptides, or small molecules, using our innovative immuno-oncology assays. With the help of our advanced platform, we can demonstrate the binding and functional properties of your molecule and its potential mechanism of action. https://immune-checkpoint.creative-biolabs.com/immune-checkpoint-assays.htm